A2 Milk (ASX:A2M): New Formula For Success
Marc Kennis, January 15, 2022
Got milk? Why we are getting bullish on A2 Milk
The dogs of the ASX in 2021 had several names you can instantly think of – Nuix, Crown, AGL and perhaps – the worst of them all – A2 Milk (ASX:A2M).
The company is the subject of two class action claims over its consistent downgrades in earnings. In late October during an investor day, Chief executive David Bortolussi outlined his new plan to overhaul its China strategy, which meant operating margins will be sacrificed for revenue growth.
What are the Best ASX Stocks to invest in right now?
Check our buy/sell tips on the top Stocks in ASX
More recently, chairman David Hearn responded to shareholders’ concerns by saying the various updates were based on “the best information we had at the time.”
Enter Stuart Roberts from Stocks Down Under who says the worst days are behind us. Why? Listen in for his reasoning.
Disclosure: Stocks Down Under directors own shares in A2M.
Want to stay up-to-date on ASX-listed stocks?
Make sure you subscribe to Stocks Down Under today!
Get a 14-day FREE TRIAL to CONCIERGE now
No credit card needed and the trial expires automatically.
Frequently Asked Questions about A2 Milk
- Is A2 Milk an Australian company?
No, A2M was founded in New Zealand, but has its primary stock market listing on the Australian ASX. It also operates a number of farms in Australia.
- What is so special about a2 milk?
A2 milk only contains the A2 beta-casein protein, not the A1 protein. A1 milk can potentially negatively affect the immunohormonal system and contribute to type 1 diabetes or heart disease. So, A2 milk is healthier for you.
- Does A2M pay a dividend?
No, A2M does not pay a dividend, but instead reinvests funds in the growth of its business.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Trump vs. Jerome Powell: What Happens to the Market If Powell Is Fired?
The relationship between President Donald Trump and Federal Reserve Chair Jerome Powell has often been tumultuous, particularly around decisions regarding…
Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!
What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…
Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?
Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…